Today: 21 May 2026
Browse Category

NYSE:SHEL 14 December 2025 - 18 January 2026

Oil stocks brace for holiday week as Chevron Venezuela license and $60 oil collide

Oil stocks brace for holiday week as Chevron Venezuela license and $60 oil collide

Chevron is set to gain expanded rights in Venezuela, allowing cash payments to the government and full crude sales, U.S. Energy Secretary Chris Wright said Friday. Brent crude closed at $64.13 a barrel, up 0.6%, while Chevron shares ended nearly flat at $166.26. The U.S. dismissed reports of using Venezuelan oil to refill the Strategic Petroleum Reserve. North American rig count rose by 28 to 769, with U.S. rigs down by one.
18 January 2026
········
Shell stock in focus for Monday as Venezuela sanctions could ease “next week” and buybacks roll on

Shell stock in focus for Monday as Venezuela sanctions could ease “next week” and buybacks roll on

Shell shares rose 3.04% in London to 26.40 pounds Friday after the company announced further share buybacks for cancellation. U.S.-listed shares closed up 0.7%. Traders are watching for a possible easing of Venezuela oil sanctions next week, which could affect crude prices. The FTSE 100 ended at a record high, lifted by energy stocks and a strong U.S. jobs report.
10 January 2026
···
Crude oil price stock jumps before the open as Venezuela talks and Iran unrest lift oil-linked shares

Crude oil price stock jumps before the open as Venezuela talks and Iran unrest lift oil-linked shares

Chevron rose 2.6%, Exxon Mobil 3.7%, and ConocoPhillips 5.1% in U.S. premarket trading as oil prices edged up. The White House plans to meet Friday with major oil companies to discuss investment in Venezuela’s energy sector. Brent crude climbed 0.7% to $62.42 a barrel, while WTI gained 0.7% to $58.17. U.S. crude inventories fell by 3.8 million barrels last week, while gasoline stocks rose sharply.
9 January 2026
··········
Shell stock in focus after Q4 update flags chemicals loss and weaker trading

Shell stock in focus after Q4 update flags chemicals loss and weaker trading

Shell warned its Chemicals and Products segment will post adjusted earnings below break-even in Q4, citing weaker margins and lower trading. Shell’s ADRs closed down 1.9% in New York at $71.54; London shares fell 3.3% to £26.56. The company also flagged a $1.5 billion cash outflow for German emissions certificates. Investors await full results on Feb. 5.
8 January 2026
···
Shell plc stock slips in premarket as oil prices ease after Venezuela upheaval

Shell plc stock slips in premarket as oil prices ease after Venezuela upheaval

Shell’s U.S.-listed shares dropped 1.6% to $74.20 in premarket trading Monday, following a 2.7% rise Friday. The move came as oil prices slipped after Washington’s seizure of Venezuelan President Nicolas Maduro, with Brent crude down 0.8% to $60.26 a barrel. OPEC+ kept its output policy unchanged. Shell plans to complete a $3.5 billion share buyback before reporting results on Feb. 5.
5 January 2026
···
Shell stock jumps to start 2026 as buyback update lands ahead of OPEC+ meeting

Shell stock jumps to start 2026 as buyback update lands ahead of OPEC+ meeting

Shell’s U.S.-listed shares rose 2.7% to $75.44 on Friday after the company disclosed new share repurchases for cancellation. Shell bought back about 1.48 million shares on Jan. 2 as part of a $3.5 billion buyback program. Oil futures ended slightly lower ahead of an OPEC+ meeting this weekend. Shell’s next results and dividend announcement are set for Feb. 5.
3 January 2026
·····
Shell Plc Stock (SHEL) News on Dec. 26, 2025: Buybacks, Gulf Discoveries, and Analyst Forecasts Into 2026

Shell Plc Stock (SHEL) News on Dec. 26, 2025: Buybacks, Gulf Discoveries, and Analyst Forecasts Into 2026

Shell’s ADR closed at $72.84 on Dec. 24, 2025, with after-hours quotes near $72.80. The six-month restriction barring Shell from bidding for BP expired Dec. 26, but CEO Wael Sawan has signaled a preference for buybacks over acquisitions. Shell is midway through a $3.5 billion buyback program set to finish before Q4 results. The stock’s 12-month range is $58.54 to $77.47.
26 December 2025
··
Shell Plc Stock News Today (Dec. 24, 2025): Buyback Update, Q4 Results Date, Analyst Forecasts, and What Investors Are Watching

Shell Plc Stock News Today (Dec. 24, 2025): Buyback Update, Q4 Results Date, Analyst Forecasts, and What Investors Are Watching

Shell reported new share buybacks on Dec. 23, purchasing 730,152 shares in London and 726,004 in Amsterdam for cancellation as part of its ongoing $3.5 billion repurchase program. The company’s U.S. shares closed at $73.07 and London shares at 2,702.00 GBp on Dec. 23. Shell’s next major update is scheduled for Jan. 8, 2026, with full Q4 results and dividend details due Feb. 5.
24 December 2025
····
Shell Plc Stock (SHEL) Today: Dividend Payment, Buybacks, New Projects and Analyst Forecasts — Dec. 18, 2025

Shell Plc Stock (SHEL) Today: Dividend Payment, Buybacks, New Projects and Analyst Forecasts — Dec. 18, 2025

Shell’s U.S.-listed shares traded near $71.55 early Thursday as oil prices climbed, with WTI at $56.38 and Brent at $60.10 amid new geopolitical tensions. Shell confirmed its next dividend of $0.358 per share will be paid Dec. 18, 2025, to shareholders on record Nov. 14. The company continues share buybacks and announced new project approvals and drilling plans.
18 December 2025
···
Shell Plc (SHEL) News Today, 17 Dec 2025: Kaikias Waterflood Greenlight, Schwedt Refinery Exit Talks, Buybacks Continue, and Nigeria Gas Expansion

Shell Plc (SHEL) News Today, 17 Dec 2025: Kaikias Waterflood Greenlight, Schwedt Refinery Exit Talks, Buybacks Continue, and Nigeria Gas Expansion

Shell approved a waterflood project at its Kaikias field in the U.S. Gulf of Mexico, aiming to boost recoverable oil by 60 million barrels. The company also resumed efforts to sell its Schwedt refinery stake in Germany, continued a $3.5 billion share buyback, and expanded gas distribution in Nigeria. Shell shares traded at $70.46, down 2.45% in U.S. markets.
17 December 2025
Shell Plc Stock (SHEL) News Today: Buybacks, Gulf of Mexico Kaikias Project, and Analyst Forecasts on December 17, 2025

Shell Plc Stock (SHEL) News Today: Buybacks, Gulf of Mexico Kaikias Project, and Analyst Forecasts on December 17, 2025

Shell shares fell 2.45% to $70.46 in U.S. trading as oil prices hit their lowest since early 2021, pressuring energy stocks. The company approved a new waterflood project at its Kaikias field in the Gulf of Mexico, aiming to add 60 million barrels of recoverable oil. Shell also revived efforts to exit a German refinery. Analysts are watching shareholder returns as crude weakness tests cash flow.
17 December 2025
·
Shell Plc Stock (SHEL) Today: UK Audit Probe, Buybacks, Dividend Timing, and Analyst Forecasts (Dec. 15, 2025)

Shell Plc Stock (SHEL) Today: UK Audit Probe, Buybacks, Dividend Timing, and Analyst Forecasts (Dec. 15, 2025)

The UK’s Financial Reporting Council has opened an investigation into Ernst & Young’s audit of Shell’s 2024 financial statements, citing possible breaches of audit partner rotation rules. Shell shares opened at 2,707p in London on Dec. 15, up from 2,686.5p. Shell continues its $3.5 billion share buyback program and approaches a dividend payment date.
15 December 2025
···
Energy Supermajors US Stocks Week Ahead: Exxon, Chevron, Shell, BP and TotalEnergies Brace for 2026 “Oil Glut” Narratives (Updated Dec. 14, 2025)

Energy Supermajors US Stocks Week Ahead: Exxon, Chevron, Shell, BP and TotalEnergies Brace for 2026 “Oil Glut” Narratives (Updated Dec. 14, 2025)

Oil prices fell over 4% last week, with Brent settling near $61 and WTI at $57.60, as traders weighed oversupply fears and peace talk signals. Exxon Mobil, Chevron, Shell, BP, and TotalEnergies all closed lower Friday. The EIA expects global inventories to rise through 2026 and Brent to average $55 per barrel that year. Investors remain split between supply concerns and company-specific catalysts.
14 December 2025
·······
1 2 3 4

Stock Market Today

  • 3 Middle Eastern Penny Stocks With Market Caps Over US$3M
    May 21, 2026, 12:54 AM EDT. Investors cautious amid geopolitical risks and volatile oil. Three Middle Eastern penny stocks spotlighted for strong financials despite challenges. Airtouch Solar Ltd (market cap ₪15.08M) cut losses 11% annually, with revenue of ₪38.03M but increased net loss of ₪8.12M, maintaining more cash than debt and a 3-year cash runway. Big Tech 50 R&D (market cap ₪10.75M) is pre-revenue, reducing net loss to $2.85M, debt-free with 3+ years cash runway, led by an experienced board. Sonovia Ltd (market cap ₪9.27M) develops anti-bacterial textiles, details limited in the report. These firms show potential in under-the-radar Middle Eastern markets amid uncertain environment.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop